Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · IEX Real-Time Price · USD
571.73
-5.66 (-0.98%)
Apr 25, 2024, 4:00 PM EDT - Market closed
Thermo Fisher Market Cap
Thermo Fisher has a market cap or net worth of $218.24 billion as of April 25, 2024. Its market cap has decreased by -2.36% in one year.
Market Cap
218.24B
Enterprise Value
245.08B
1-Year Change
-2.36%
Ranking
Category
Stock Price
$571.73
Market Cap Chart
Since December 1, 1998, Thermo Fisher's market cap has increased from $2.71B to $218.24B, an increase of 7,953.93%. That is a compound annual growth rate of 18.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2024 | 218.01B | -0.98% |
| Apr 24, 2024 | 220.17B | 0.49% |
| Apr 23, 2024 | 219.10B | 4.78% |
| Apr 22, 2024 | 209.10B | 0.66% |
| Apr 19, 2024 | 207.73B | 0.60% |
| Apr 18, 2024 | 206.49B | -1.05% |
| Apr 17, 2024 | 208.67B | -1.32% |
| Apr 16, 2024 | 211.46B | -0.60% |
| Apr 15, 2024 | 212.72B | -1.30% |
| Apr 12, 2024 | 215.53B | -1.63% |
| Apr 11, 2024 | 219.09B | 0.15% |
| Apr 10, 2024 | 218.76B | -2.63% |
| Apr 9, 2024 | 224.67B | 1.80% |
| Apr 8, 2024 | 220.70B | -0.11% |
| Apr 5, 2024 | 220.96B | 1.55% |
| Apr 4, 2024 | 217.58B | -0.94% |
| Apr 3, 2024 | 219.64B | 0.78% |
| Apr 2, 2024 | 217.94B | -1.02% |
| Apr 1, 2024 | 220.19B | -0.65% |
| Mar 28, 2024 | 221.62B | 0.32% |
| Mar 27, 2024 | 220.92B | 1.85% |
| Mar 26, 2024 | 216.90B | -0.83% |
| Mar 25, 2024 | 218.71B | -1.63% |
| Mar 22, 2024 | 222.34B | -0.18% |
| Mar 21, 2024 | 222.74B | 0.70% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UnitedHealth Group | 448.23B |
| Johnson & Johnson | 360.41B |
| Merck & Co. | 321.34B |
| AbbVie | 300.20B |
| AstraZeneca | 219.62B |
| Novartis AG | 190.33B |
| Danaher | 187.44B |
| Abbott Laboratories | 186.69B |